A whistleblower's kickback lawsuit against McKesson, a major pharmaceutical distributor, has been revived. The lawsuit alleges that McKesson engaged in illegal kickback schemes to boost sales of its drugs.
The whistleblower, who worked for McKesson, claims that the company offered discounts and rebates to pharmacies in exchange for promoting its products. These kickbacks allegedly violated the Anti-Kickback Statute, which prohibits the exchange of remuneration for referrals of services or items reimbursed by federal healthcare programs.
